Find Clinical Trial

Study of a New Intravenous Drug, Called S065487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma or Multiple Myeloma


← Back
Study Phase

Phase 1

Therapeutic Area

Cancers

IndicationBlood cancer
SponsorInstitut de Recherches Internationales Servier
Active substance/
Medical device

S065487

Active Substance CodeS065487
Protocol CodeCL1-65487-002
EudraCT Code2018-004170-97
NCT CodeNCT03755154


Documents and links

Results are not yet available.



Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility